Professor
1. The Levine Cancer Institute, Division of Hematological Oncology and Blood Disorders, Atrium Health, Charlotte NC, 6. Novo Nordisk A/S, Rare Disease Division, Zurich, Switzerland, New Jersey, United States
Disclosure information not submitted.
IMPLEMENTING HEALTH CARE TRANSITION PROCESS FOR SICKLE CELL USING QUALITY IMPROVEMENT
Saturday, June 17, 2023
9:00 AM – 9:15 AM East Coast USA Time